Ongoing transmission of trachoma in low prevalence districts in Mozambique: results from four cross-sectional enhanced impact surveys, 2022.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 10 2024
Historique:
received: 26 01 2024
accepted: 26 08 2024
medline: 16 10 2024
pubmed: 16 10 2024
entrez: 15 10 2024
Statut: epublish

Résumé

Mozambique is making progress towards elimination of trachoma as a public health problem, but in some districts trachomatous inflammation-follicular (TF) prevalence remains above the 5% elimination threshold despite years of various interventions, including antibiotic mass drug administration. To characterize transmission in four districts, we incorporated testing of ocular infection and serology into routine trachoma impact surveys (TIS) in August 2022. We examined residents aged ≥ 1 year for trachoma and collected information on household water, sanitation, and hygiene. Among children aged 1-9 years, we tested conjunctival swabs for Chlamydia trachomatis nucleic acid and dried blood spots for C. trachomatis antibodies. We modeled age-dependent seroprevalence to estimate seroconversion rate (SCR). We examined 4841 children aged 1-9 years. TF prevalence ranged between 1.1 and 6.0% with three districts below the 5% threshold. PCR-confirmed infection prevalence ranged between 1.1 and 4.8%, and Pgp3 seroprevalence ranged between 8.8 and 24.3%. Pgp3 SCR was 1.9 per 100 children per year in the district with the lowest TF prevalence. Two other districts with TF < 5% had SCR of 5.0 and 4.7. The district with TF ≥ 5% had a SCR of 6.0. This enhanced TIS furthered understanding of transmission in these districts and provides information on additional indicators for monitoring trachoma programs.

Identifiants

pubmed: 39406720
doi: 10.1038/s41598-024-71201-z
pii: 10.1038/s41598-024-71201-z
doi:

Substances chimiques

Antibodies, Bacterial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

22842

Informations de copyright

© 2024. The Author(s).

Références

Flaxman, S. R. et al. Global causes of blindness and distance vision impairment 1990–2020: A systematic review and meta-analysis. Lancet Glob. Health 5, e1221–e1234 (2017).
doi: 10.1016/S2214-109X(17)30393-5 pubmed: 29032195
Solomon, A. W. et al. Trachoma. Nat. Rev. Dis. Primers 8, 1–20 (2022).
doi: 10.1038/s41572-022-00359-5
WHO. Ending the Neglect to Attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021–2030. https://www.who.int/publications/i/item/9789240010352 (2021).
WHO. Global Elimination of Blinding Trachoma. https://iris.who.int/handle/10665/79806 (1998).
West, S. K. Blinding trachoma: Prevention with the safe strategy. Am. J. Trop. Med. Hygiene 69, 18–23 (2003).
doi: 10.4269/ajtmh.2003.69.18
Francis, V. & Turner, V. Achieving Community Support for Trachoma Control. https://www.who.int/publications/i/item/WHO-PBL-93.36 (1995).
WHO. WHO Alliance for the Global Elimination of Trachoma: Progress report on elimination of trachoma, 2022. Weekly Epidemiol. Rec. 98, 297–314 (2023).
WHO. Iraq eliminates trachoma as a public health problem. https://www.who.int/news/item/31-07-2023-iraq-eliminates-trachoma-as-a-public-health-problem (2023).
WHO. Validation of Elimination of Trachoma as a Public Health Problem. https://www.who.int/publications/i/item/who-htm-ntd-2016.8 (2016).
Thylefors, B., Dawson, C. R., Jones, B. R., West, S. K. & Taylor, H. R. A simple system for the assessment of trachoma and its complications. Bull. World Health Organ. 65, 477–483 (1987).
pubmed: 3500800 pmcid: 2491032
Solomon, A. W. et al. The simplified trachoma grading system, amended. Bull. World Health Organ. 98, 698–705 (2020).
doi: 10.2471/BLT.19.248708 pubmed: 33177759 pmcid: 7652564
WHO. Informal Consultation on End-Game Challenges for Trachoma Elimination, Task Force for Global Health, Decatur, United States of America, 7–9 December 2021. https://apps.who.int/iris/handle/10665/363591 (2022).
Ngondi, J. et al. Evaluation of three years of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness and Environmental improvement) for trachoma control in five districts of Ethiopia hyperendemic for trachoma. Trans. R. Soc. Trop. Med. Hygiene 103, 1001–1010 (2009).
doi: 10.1016/j.trstmh.2008.11.023
Goodhew, E. B. et al. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl. Trop. Dis. 6, e1873 (2012).
doi: 10.1371/journal.pntd.0001873 pubmed: 23133684 pmcid: 3486877
Martin, D. L. et al. Serology for trachoma surveillance after cessation of mass drug administration. PLoS Negl. Trop. Dis. 9, e0003555 (2015).
doi: 10.1371/journal.pntd.0003555 pubmed: 25714363 pmcid: 4340913
Martin, D. L. et al. Serological measures of trachoma transmission intensity. Sci. Rep. 5, 18532 (2015).
doi: 10.1038/srep18532 pubmed: 26687891 pmcid: 4685243
West, S. K. et al. Can we use antibodies to chlamydia trachomatis as a surveillance tool for national trachoma control programs? Results from a district survey. PLOS Neglect. Trop. Diseases 10, e0004352 (2016).
doi: 10.1371/journal.pntd.0004352
Pinsent, A. et al. The utility of serology for elimination surveillance of trachoma. Nat. Commun. 9, 5444 (2018).
doi: 10.1038/s41467-018-07852-0 pubmed: 30575720 pmcid: 6303365
Burr, S. E. et al. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: Cross-sectional surveys in six evaluation units. PLoS Negl. Trop. Dis. 13, e0007749 (2019).
doi: 10.1371/journal.pntd.0007749 pubmed: 31658258 pmcid: 6816554
Senyonjo, L. G. et al. Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem. PLoS Negl. Trop. Dis. 12, e0007027 (2018).
doi: 10.1371/journal.pntd.0007027 pubmed: 30550537 pmcid: 6310292
Gwyn, S. et al. Comparison of platforms for testing antibodies to Chlamydia trachomatis antigens in the Democratic Republic of the Congo and Togo. Sci. Rep. 11, 7225 (2021).
doi: 10.1038/s41598-021-86639-8 pubmed: 33790370 pmcid: 8012353
Abdala, M. et al. The epidemiology of trachoma in Mozambique: Results of 96 population-based prevalence surveys. Ophthalm. Epidemiol. 25, 201–210 (2018).
doi: 10.1080/09286586.2017.1351996
WHO. Design Parameters for Population-Based Trachoma Prevalence Surveys: Strategic and Technical Advisory Group for Neglected Tropical Diseases, Working Group on Monitoring and Evaluation. https://apps.who.int/iris/handle/10665/275523 (2018).
Solomon, A. W. et al. Trachoma Control: A Guide for Programme Managers. https://www.who.int/publications/i/item/9241546905 (2006).
Courtright, P. et al. Tropical Data: Training System for Trachoma Prevalence Surveys (Version 3). https://dyzz9obi78pm5.cloudfront.net/app/image/id/609bd439ec161cdf5109624d/n/td-trainingmanual-may21-v31-en-lrc.pdf (2019).
Solomon, A. W., Le Mesurier, R. T. & Williams, W. J. A diagnostic instrument to help field graders evaluate active trachoma. Ophthalm. Epidemiol. 25, 399–402 (2018).
doi: 10.1080/09286586.2018.1500616
Ray, K. J. et al. Estimating community prevalence of ocular Chlamydia trachomatis infection using pooled polymerase chain reaction testing. Ophthalm. Epidemiol. 21, 86–91 (2014).
doi: 10.3109/09286586.2014.884600
Solomon, A. W. et al. The global trachoma mapping project: Methodology of a 34-country population-based study. Ophthalm. Epidemiol. 22, 214–225 (2015).
doi: 10.3109/09286586.2015.1037401
Tedijanto, C. et al. Monitoring transmission intensity of trachoma with serology. Nat. Commun. 14, 3269 (2023).
doi: 10.1038/s41467-023-38940-5 pubmed: 37277341 pmcid: 10241377
Solomon, A. W. et al. Strategies for control of trachoma: Observational study with quantitative PCR. Lancet 362, 198–204 (2003).
doi: 10.1016/S0140-6736(03)13909-8 pubmed: 12885481
WHO/UNICEF. Core Questions on Drinking Water, Sanitation and Hygiene for Household Surveys: 2018 Update. https://washdata.org/sites/default/files/documents/reports/2019-03/JMP-2018-core-questions-for-household-surveys.pdf (2018).
Patton, M. Q. Enhancing the quality and credibility of qualitative analysis. Health Serv. Res. 34, 1189–1208 (1999).
pubmed: 10591279 pmcid: 1089059
Nash, S. D. et al. Prevalence of ocular chlamydia trachomatis infection in Amhara Region, Ethiopia, after 8 Years of Trachoma Control Interventions. Am. J. Trop. Med. Hyg. 108, 261–267 (2023).
doi: 10.4269/ajtmh.22-0535 pubmed: 36623484 pmcid: 9896333
WHO/UNICEF. Core Questions on Drinking-Water and Sanitation for Household Surveys. (2006).
Emerson, P. M., Bailey, R. L., Mahdi, O. S., Walraven, G. E. & Lindsay, S. W. Transmission ecology of the fly Musca sorbens, a putative vector of trachoma. Trans. R. Soc. Trop. Med. Hygiene 94, 28–32 (2000).
doi: 10.1016/S0035-9203(00)90427-9
Emerson, P. M., Bailey, R. L., Walraven, G. E. & Lindsay, S. W. Human and other faeces as breeding media of the trachoma vector Musca sorbens. Med. Vet. Entomol. 15, 314–320 (2001).
doi: 10.1046/j.0269-283x.2001.00318.x pubmed: 11583450
Last, A. et al. Detecting extra-ocular Chlamydia trachomatis in a trachoma-endemic community in Ethiopia: Identifying potential routes of transmission. PLOS Negl. Trop. Diseases 14, e0008120 (2020).
doi: 10.1371/journal.pntd.0008120
Freeman, M. C. et al. The impact of sanitation on infectious disease and nutritional status: A systematic review and meta-analysis. Int. J. Hygiene Environ. Health 220, 928–949 (2017).
doi: 10.1016/j.ijheh.2017.05.007
Oswald, W. E. et al. Active trachoma and community use of sanitation, Ethiopia. Bull. World Health Organ. 95, 250–260 (2017).
doi: 10.2471/BLT.16.177758 pubmed: 28479620 pmcid: 5407250
Garn, J. V. et al. Sanitation and water supply coverage thresholds associated with active trachoma: Modeling cross-sectional data from 13 countries. PLoS Negl. Trop. Diseases 12, e0006110 (2018).
doi: 10.1371/journal.pntd.0006110
West, S. et al. Water availability and trachoma. Bull. World Health Organ. 67, 71–75 (1989).
pubmed: 2706728 pmcid: 2491213
Baggaley, R. F. et al. Distance to water source and altitude in relation to active trachoma in Rombo district, Tanzania. Trop. Med. Int. Health 11, 220–227 (2006).
doi: 10.1111/j.1365-3156.2005.01553.x pubmed: 16451347 pmcid: 6855913
Wolle, M. A. & West, S. K. Ocular Chlamydia trachomatis infection: Elimination with mass drug administration. Exp. Rev. Anti-infective Therapy 17, 189–200 (2019).
doi: 10.1080/14787210.2019.1577136

Auteurs

Henis Mior Sitoe (HM)

Ministério da Saúde, Maputo, Mozambique.

William E Oswald (WE)

RTI International, Research Triangle Park, USA. woswald@rti.org.

Felizmina Zita (F)

Ministério da Saúde, Maputo, Mozambique.

Mawo Fall (M)

RTI International, Maputo, Mozambique.

Tamimo Momade (T)

RTI International, Maputo, Mozambique.

Molly W Adams (MW)

RTI International, Research Triangle Park, USA.

Rebecca M Flueckiger (RM)

RTI International, Research Triangle Park, USA.

Scott McPherson (S)

RTI International, Research Triangle Park, USA.

Sabrina Eyob (S)

RTI International, Research Triangle Park, USA.

Thuy Doan (T)

F.I. Proctor Foundation and University of California San Francisco, San Francisco, USA.

Thomas M Lietman (TM)

F.I. Proctor Foundation and University of California San Francisco, San Francisco, USA.

Benjamin F Arnold (BF)

F.I. Proctor Foundation and University of California San Francisco, San Francisco, USA.

Karana Wickens (K)

Oak Ridge Institute for Science and Education, Oak Ridge, USA.

Sarah Gwyn (S)

Centers for Disease Control and Prevention, Atlanta, USA.

Diana L Martin (DL)

Centers for Disease Control and Prevention, Atlanta, USA.

Mabula Kasubi (M)

Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Sarah Boyd (S)

International Trachoma Initiative, Task Force for Global Health, Decatur, USA.

Ana Bakhtiari (A)

International Trachoma Initiative, Task Force for Global Health, Decatur, USA.

Cristina Jimenez (C)

Sightsavers, Haywards Heath, UK.

Anthony W Solomon (AW)

Global Neglected Tropical Diseases Programme, World Health Organization, Geneva, Switzerland.

Emma M Harding-Esch (EM)

London School of Hygiene & Tropical Medicine, London, UK.

Upendo J Mwingira (UJ)

RTI International, Research Triangle Park, USA.

Jeremiah M Ngondi (JM)

RTI International, Research Triangle Park, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH